Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular Carcinoma
GALAD and ASAP models demonstrate superior diagnostic efficacy for HCC compared to individual biomarkers, and their performance is significantly influenced by the immunoassay platform employed.
Authors
- Rui Ding (ORCID: https://orcid.org/0000-0003-0406-5939)
- Jie Niu
- Guan-Hua Wang
- Yue Cui
- Peng Li
- Yuan Huang
- Xu-Zhen Qin
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Capital Institute of Pediatrics (CN)
- Beijing Children’s Hospital (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2026-01-01
- DOI
- https://doi.org/10.2147/jhc.s554305
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences